Oleg Nodelman
@Ecor1 Capital, Llc
Latest period2024 - Q3ReportedManaged Assets$2.922BTotal holdings63
Assets growth rate-10.62%Assets growth rate (2-Q avg)-13.97%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Ecor1 Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 63 positions.
Assets under management
The assets under management (AUM) of Ecor1 Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.922B in assets, with a quarterly growth rate of -10.62% and a 2-quarter average growth rate of -13.97%. The portfolio is managed by Oleg Nodelman, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
ARTVArtiva Biotherapeutics Inc
| 0.03% | $640,449 41,453 shares@ $15.46 avg price | New Position |
DSGNDesign Therapeutics Inc
| 0.01% | $289,627 53,834 shares@ $5.39 avg price | New Position |
MGNXMacrogenics Inc
| 0.01% | $184,299 56,018 shares@ $3.29 avg price | New Position |
ALLKAllakos Inc
| 0.01% | $125,640 192,346 shares@ $0.66 avg price | New Position |